KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Tax Rate (2021 - 2026)

Biocryst Pharmaceuticals filings provide 5 years of Tax Rate readings, the most recent being 0.88% for Q4 2025.

  • On a quarterly basis, Tax Rate rose 397.0% to 0.88% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.32%, a 354.0% increase, with the full-year FY2025 number at 1.32%, up 354.0% from a year prior.
  • Tax Rate hit 0.88% in Q4 2025 for Biocryst Pharmaceuticals, up from 6.34% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 95.78% in Q1 2025 to a low of 14.51% in Q4 2021.
  • Median Tax Rate over the past 5 years was 1.04% (2024), compared with a mean of 4.76%.
  • Biggest five-year swings in Tax Rate: crashed -536bps in 2024 and later skyrocketed 9682bps in 2025.
  • Biocryst Pharmaceuticals' Tax Rate stood at 14.51% in 2021, then soared by 99bps to 0.11% in 2022, then skyrocketed by 2230bps to 2.27% in 2023, then plummeted by -237bps to 3.09% in 2024, then soared by 128bps to 0.88% in 2025.
  • The last three reported values for Tax Rate were 0.88% (Q4 2025), 6.34% (Q3 2025), and 21.6% (Q2 2025) per Business Quant data.